Leela Barham

Leela Barham

Leela Barham's picture

Latest posts from :

Access and Evidence

Early Access to Medicines Scheme:...

Dec 21, 2015

The first product has now gone completely through EAMS: what lessons can other...

Access and Evidence

Scotland: Doing Things Differently

May 29, 2015

Doubling of Scottish New Medicines Fund: Good or Bad?

Access and Evidence

Early access: Taking stock of the...

Mar 4, 2015

But just when is access really early, and what are the options for companies to...

Access and Evidence

First steps on the way to earlier...

Oct 7, 2014

Speed of access matters

Access and Evidence

Market access: How to engage...

Nov 6, 2011

Leela Barham reports on how the pharma industry can make the most of working...

Commercial, Access and Evidence

Merging market access with launch...

Sep 25, 2011

Leela Barham looks at how bringing together launch and market access plans can...

Commercial

Market access: The impact of HTAs...

Sep 1, 2011

Leela Barham explores how different HTA approaches could affect market access...

Commercial

The impact of value-based pricing...

Aug 2, 2011

Leela Barham explores the potential effect of value-based pricing on...

Commercial

Pharma and the ‘new’ NHS:...

Jul 12, 2011

Leela Barham looks at the proposed reforms of the NHS in England and what they...

Commercial

The 'new' NHS: What does...

Jun 13, 2011

Leela Barham looks at the proposed reforms of the NHS in England and what they...

Pages